Ecklonia cava extract dedifferentiates mesenchymal stem cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing induced pluripotent stem cells from mesenchymal stem cells face challenges in safety, efficiency, and ethical concerns, with existing techniques being inefficient and risky, particularly when using viral vectors or requiring large numbers of eggs.
Innovation Solution
A medium composition containing Ecklonia cava extract is used to dedifferentiate mesenchymal stem cells into induced pluripotent stem cells, which can then be differentiated into osteoblasts, offering a safe and efficient method for producing cell therapy products.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If fusion with ES cells is used to produce induced pluripotent stem cells, then pluripotent stem cells can be obtained, but the cells have two pairs of genes which causes instability
Solution Approach 1:
The patent extracts and removes the problematic viral vectors and oncogenes from the induction process. Instead of using viral fusion methods that leave behind extra gene pairs, the invention uses a purified medium composition containing specific growth factors and cytokines to induce pluripotency without introducing foreign genetic material, thereby eliminating the stability issue caused by dual gene pairs
Solution Approach 2:
The patent changes the induction parameters from genetic manipulation to biochemical signaling. By adjusting medium composition, growth factor concentrations, and culture conditions rather than altering genetic material, the method achieves pluripotent stem cell induction without the instability associated with multiple gene pairs
2Productivity
If somatic cell nuclear transfer is used to produce induced pluripotent stem cells, then pluripotent stem cells can be obtained, but it requires a large number of eggs and has very low efficiency
Solution Approach 1:
The patent enables mesenchymal stem cells to self-dedifferentiate into pluripotent stem cells through biochemical signaling in the optimized medium. This self-service mechanism eliminates the need for external egg cells or complex nuclear transfer procedures, dramatically improving production efficiency while reducing material requirements
Solution Approach 2:
Instead of following the conventional path of nuclear transfer from somatic cells to eggs, the patent inverts the approach by using medium-induced dedifferentiation of mesenchymal stem cells directly into pluripotent stem cells, bypassing the egg requirement entirely and achieving high efficiency
3Reliability
If reprogramming by gene factor using viruses containing oncogenes is used to produce induced pluripotent stem cells, then dedifferentiation can be induced, but it poses a high risk of cancer occurrence and has low efficiency
Solution Approach 1:
The patent converts the harmful effect of viral oncogenes into a beneficial approach by using purified growth factors and cytokines that naturally induce dedifferentiation without carcinogenic risks. The medium composition leverages physiological signaling pathways to achieve the same dedifferentiation effect as viral oncogenes but without the cancer risk
Solution Approach 2:
The patent introduces a safe intermediary system - a specifically formulated medium containing growth factors and cytokines - that mediates the dedifferentiation process without using direct viral gene transfer. This intermediary approach maintains production efficiency while eliminating the cancer risk associated with oncogene-containing viruses
4Productivity
If conventional medium compositions are used for culturing isolated umbilical cord mononuclear cells, then cell culture can be maintained, but the amount of pluripotent stem cells produced is limited
Solution Approach 1:
The patent optimizes culture parameters including growth factor concentrations, cytokine combinations, and medium composition to maximize pluripotent stem cell production from umbilical cord mononuclear cells. These parameter adjustments enhance differentiation efficiency without complicating the overall culture methodology
Solution Approach 2:
The optimized medium composition serves multiple functions: it maintains mesenchymal stem cell viability, induces dedifferentiation to pluripotent state, and supports high-yield production. This multi-functional medium simplifies the process by combining multiple objectives into a single culture system
Data Source
Figure 1~2
Figure 3~4
Figure 5a~6C
AI summary
The present invention relates to a medium composition containing an Ecklonia cava extract for dedifferentiation an induced pluripotent stem cell. Also, the present invention relates to a method for differentiating an induced pluripotent stem cell produced by using the medium composition into osteoblasts. When using the medium composition according to the present invention, induced pluripotent stem cells using mesenchymal stem cells can be produced efficiently, and the pluripotent stem cells which have been produced can be useful as a cell treatment agent by being capable of being differentiated into osteoblasts.